For in-vitro research use only. Not for human consumption.
P21 Adamantane
P21 Adamantane is the adamantane-modified P021-style molecule used in neurotrophic pathway research models.
P21 Adamantane definition
P21 Adamantane is the adamantane-modified P021-style molecule used in neurotrophic pathway research models. P21 Adamantane is classified as a adamantane-modified cntf-derived peptide analog. P021 / Peptide 021, an acetylated DGGL analog containing an adamantane-based amino-acid residue and C-terminal amide.. Supplied by Nexus Laboratory for in-vitro research use only — not approved for human or veterinary therapeutic use.
- CAS
- 1246751-68-7
- MW
- 578.66 g/mol
- Sequence
- Not listed
- Half-life
- Not listed
- Formula
- C27H42N6O8
- Purity
- Not listed
- Form
- Lyophilized powder
- Class
- Adamantane-modified CNTF-derived peptide analog
Reconstitution calculator
Estimate vial concentration and aliquot volume from the selected vial mass, solvent volume, and target research amount.
Calculations are for lab planning only and do not replace the product COA, protocol requirements, or qualified professional review. Confirm solvent compatibility before use.
Compound details.
- CAS Number
- 1246751-68-7
- Molecular Weight
- 578.66 g/mol
- Molecular Formula
- C27H42N6O8
- Class
- Adamantane-modified CNTF-derived peptide analog
- Physical Form
- Lyophilized powder
- Storage
- Store lyophilized material at -20C, desiccated and protected from light. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Research context.
P21 Adamantane is studied in preclinical research models examining mechanisms relevant to the neuroactive, nootropic, and cognitive research compounds. category. All Nexus Laboratory batches are documented through HPLC purity verification, mass spectrometry identity confirmation, and endotoxin screening. Compounds are supplied strictly for in-vitro and analytical research use.
Verification standard.
Every Nexus Laboratory batch ships with a Certificate of Analysis documenting HPLC purity (target ≥98%), mass spectrometry identity (expected versus observed mass), and endotoxin screening — verified by third-party laboratory testing and publicly archived. Review Nexus lab verification.
P21 Adamantane is part of the Nexus Cognitive & Nootropic catalog. Neuroactive, nootropic, and cognitive research compounds. Each listed variant is priced from the consolidated Nexus catalog and intended for qualified research use only.
TODO-COPY: replace with real compound-specific narrative.
The chemistry.
P021 / Peptide 021, an acetylated DGGL analog containing an adamantane-based amino-acid residue and C-terminal amide.
Storage: Store lyophilized material at -20C, desiccated and protected from light. After reconstitution, aliquot and avoid repeated freeze-thaw cycles.
Technical specifications.
- Product Name: P21 Adamantane
- Classification: Adamantane-modified CNTF-derived peptide analog
- Structural Description: P021 / Peptide 021, an acetylated DGGL analog containing an adamantane-based amino-acid residue and C-terminal amide.
- CAS Number: 1246751-68-7
- Molecular Weight: 578.66 g/mol
- Molecular Formula: C27H42N6O8
- Physical Form: Lyophilized powder
- Intended Use: In-vitro research use only - not for human consumption
HPLC trace preview.
Related research compounds
Same category, mechanism overlap, and common research stack pairings.
P21 Adamantane research FAQ.
What is P21 Adamantane used for in research?
P21 Adamantane is supplied for controlled in-vitro research workflows in the Cognitive & Nootropic category. It is not labeled for human or veterinary use.
Is P21 Adamantane HPLC verified?
P21 Adamantane is listed with Nexus lab verification. Current catalog records show batch-specific purity context where batch COA data is available.
Which P21 Adamantane sizes are available?
Current Nexus variants include 10mg.
Does P21 Adamantane include a COA?
Yes. The current Nexus record links P21 Adamantane to batch NEX-P21-ADAMANTANE-2026-0063.